Psymposia Aesthetics: Right-Wing Psychedelia Collage
This video was first aired as Patreon-exclusive content. Check out our Patreon at www.patreon.com/psymposia.
Psymposia
Watch
All videos
Psymposia Aesthetics: Volume #1
This video originally aired on our Patreon. You can find us there at www.patreon.com/psymposia
The Deluded Beliefs of Psychedelic Therapy Advocates
The crew discusses two presenters at the September 14, 2026 FDA public hearing on psychedelics, and the way that Silicon Valley and new age pseudoscience are coming together to create the back bone of the psychedelic therapy industry's ideology.
Psymposia Mailbag (September 2026)
The crew reads comments on their recent conversion therapy, Reggie Watts, and Alex Novell videos.
MAHA Summit — Brought to You by Psychedelic Pharma
Normie, Mike, and Neşe discuss the upcoming MAHA Summit and its psychedelic pharmaceutical sponsors.
FDA's Psychedelics Hearing Was an Industry Trade Show
The crew discusses the FDA's September 14 psychedelic hearing, including Neşe's experience being in attendance, the financial conflicts of interest at the event, and the pseudoscientific beliefs of practitioners who gave testimony.
It's Not Just Reggie Watts
Psymposia dives into the recent Rolling Stone article — "Reggie Watts Is a Prominent Ketamine Advocate. Was It His Ex’s ‘Undoing’?" — and explores how the dynamics at play in that article are pervasive within the psychedelic advocacy scene.
Andrew Callaghan Harassment, Drug Legalization, & Creating Documentaries (w/ Alex Novell)
Psymposia interviews YouTube documentarian @Alex-Novell about his experience with Andrew Callaghan and Channel 5, drug legalization, and creating documentary films.
Coming Out of the Psychedelic Closet, Ten Years Later
Psymposia discusses takeaways from their "Psychedelic Conversion Therapy" series and reflects on the ten year anniversary of their "Coming Out of the Psychedelic Closet" series.
Featured series
Hamilton’s Pharma Cope
In this conversation we address Hamilton Morris’ misinformation head on, exposing Morris’ lies and his lack of journalistic integrity.
Watch the series
Hamilton’s Pharma Cope, Part 1: “DEA Informants” Transcript
In this episode, we respond to Hamilton Morris’ claims that we are DEA informants and that we colluded with the FDA to get Lykos Therapeutics’ MDMA therapy application rejected.
Hamilton’s Pharma Cope, Part 2: Psychedelic Cult Defenders Transcript
In this episode, we examine previous smear campaigns against us related to our reporting on the Church of Psilomethoxin and Martin Ball, as well as false claims about who funds us and why.
Hamilton’s Pharma Cope, Part 3: Paid Protestor Paranoia Transcript
In this episode, we continue the conversation about our funding and explore Hamilton Morris’ conspiratorial claims about the company Usona.
Hamilton’s Pharma Cope, Part 4: “The Face of Psychedelic Journalistic Ethics” Transcript
In this episode, we continue the conversation about our funding and explore Hamilton Morris’ conspiratorial claims about the company Usona.
Psychedelic Conversion Therapy
A three-part series on the past, present and future of psychedelic conversion therapy: its history in psychedelic research, the influencers who pathologize queerness, and what it means to welcome pro-conversion therapy advocates into a movement built around “healing.”
Watch the series
Psychedelic Conversion Therapy, Part 1: The First Wave
Neşe and Russell review the history and harms of conversion therapy practices in the broader medical landscape, as well as their persistence throughout the history of psychedelic research.
Psychedelic Conversion Therapy, Part 2: From Counterculture to Culture War
Neşe and Russell examine the rise of modern right-wing influencers who simultaneously advocate for the dismantling of “woke” ideologies, express support for conversion therapy frameworks, and promote the use of psychedelic therapy.
Psychedelic Conversion Therapy, Part 3: A Handshake Away From Trump (w/ Kaleb Graves)
Neşe and Russell speak with Kaleb Graves about his reporting on the growing links between psychedelic therapy and conversion therapy movements.
Statements
Correcting the Record: What The New York Times Got Wrong
In response to The New York Times February 4 article, “How a Leftist Activist Group Helped Torpedo a Psychedelic Therapy,” Psymposia requested corrections to numerous errors and false accusations.
Correcting the Record: Addressing The New York Times’ Deceptive Coverage of Psymposia
Rather than unpacking the actual causes of Lykos Therapeutics’ disastrous Phase 3 trials and FDA rejection, The New York Times produced a work of fictitious propaganda that prioritizes corporate interests over public health.